The National Institutes of Health

The National Institutes of Health (NIH) is the United States ’s medical research agency.

LiverTF - Liver-enriched Transcription Factors as Prognostic Markers and Therapeutic Targets in Alcoholic Hepatitis

PI: SANCHO BRU, PAU
Funding: National Institutes of Health (NIH)
Beneficiary organization: IDIBAPS
Reference: 1U01AA026972-01
Amount: 28,621.19 €
Duration: 22/09/2018 to 30/06/2019

Molecular Diagnosis, Prognosis, and Therapeutic Targets in Mantle Cell Lymphoma

PI: CAMPO GUERRI, ELIAS
Funding: National Institutes of Health (NIH)
Beneficiary organization: IDIBAPS
Reference: NIH_PAR-16-457_01
Amount: 181,829 €
Duration: 19/09/2018 to 31/08/2023

CREST2 - Carotid Revascularization and Medical Management for Asymptomatic Carotid Stenosis Trial

PI: CHAMORRO SANCHEZ, ANGEL
Funding: National Institutes of Health (NIH)
Beneficiary organization: IDIBAPS
Reference: 5U01NS080168-05
Amount: 6,000 €
Duration: 01/03/2018 to 28/02/2021

The Moderate Alcohol and Cardiovascular Health Trial

PI: ESTRUCH RIBA, RAMON
Funding: National Institutes of Health (NIH)
Beneficiary organization: IDIBAPS
Reference: 38685
Amount: 208,918.18 €
Duration: 30/09/2016 to 31/03/2019

Development of microRNA Biomarkers For Noninvasive Detection of Colorectal Cancer

PI: BALAGUER PRUNES, FRANCESC
Funding: National Institutes of Health (NIH)
Beneficiary organization: IDIBAPS
Reference: 1R01CA184792-01A1
Amount: 38,797.96 €
Duration: 01/07/2015 to 30/06/2020

Methylation Biomarker Development for noninvasive detection of Colorectal Cancer

PI: BALAGUER PRUNES, FRANCESC
Funding: National Institutes of Health (NIH)
Beneficiary organization: IDIBAPS
Reference: 1R01CA181572
Amount: 60,523.53 €
Duration: 01/05/2014 to 30/04/2019